After Reaching Milestone, Is Transenterix Inc (NYSEAMERICAN:TRXC)’s Short Interest Revealing Something?

October 13, 2018 - By Hazel Jackson

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Logo

Investors sentiment increased to 2.15 in Q2 2018. Its up 0.51, from 1.64 in 2018Q1. It improved, as 15 investors sold TransEnterix, Inc. shares while 18 reduced holdings. 47 funds opened positions while 24 raised stakes. 59.38 million shares or 18.11% more from 50.28 million shares in 2018Q1 were reported.
The New York-based Capstone Investment Advisors Ltd Com has invested 0.01% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Tradewinds Capital Management Limited Liability Co holds 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC) or 200 shares. Jfs Wealth Advisors Ltd Liability Corp reported 500 shares. Aqr Management Ltd Liability reported 403,613 shares stake. Essex Limited Liability Corporation invested in 0.01% or 13,166 shares. 101,449 are owned by Jane Street Grp Incorporated Lc. Ameritas Investment Ptnrs stated it has 0% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Wells Fargo Mn holds 0% of its portfolio in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 120,044 shares. The Switzerland-based Credit Suisse Ag has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Balyasny Asset Mngmt Limited Liability Corporation holds 225,357 shares. State Street Corp holds 3.29M shares or 0% of its portfolio. Maryland Cap Mngmt accumulated 80,375 shares or 0.05% of the stock. Invesco Ltd owns 41,872 shares. Parametric Portfolio Assocs Lc owns 14,095 shares or 0% of their US portfolio. Lifeplan Financial Group Incorporated Incorporated has 0% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 1,000 shares.

Since June 1, 2018, it had 0 insider buys, and 6 selling transactions for $7.64 million activity. Fernando Anthony C. J. sold 27,000 shares worth $99,090. $1.78M worth of TransEnterix, Inc. (NYSEAMERICAN:TRXC) was sold by Pope Todd.

The stock of Transenterix Inc (NYSEAMERICAN:TRXC) registered a decrease of 4.04% in short interest. TRXC’s total short interest was 31.38 million shares in October as published by FINRA. Its down 4.04% from 32.71M shares, reported previously. With 5.24M shares average volume, it will take short sellers 6 days to cover their TRXC’s short positions.

The stock decreased 1.85% or $0.09 during the last trading session, reaching $4.78. About 6.91M shares traded or 6.98% up from the average. TransEnterix, Inc. (NYSEAMERICAN:TRXC) has risen 330.95% since October 13, 2017 and is uptrending. It has outperformed by 315.33% the S&P500.

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems. The company has market cap of $1.00 billion. The firm offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It currently has negative earnings. It also develops SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.

Another recent and important TransEnterix, Inc. (NYSEAMERICAN:TRXC) news was published by which published an article titled: “TransEnterix’s MST Medical Buyout to Boost Senhance Platform” on September 24, 2018.

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.